Ingenuity and resiliency of syringe service programs on the front lines of the opioid overdose and COVID-19 crises
Lynn D. Wenger, Alex H. Kral, Ricky N. Bluthenthal, Terry Morris, Lee Ongais, Barrot H. Lambdin
Topics & Concepts
IngenuitySyringeCoronavirus disease 2019 (COVID-19)Opioid epidemicBuprenorphineMedicine2019-20 coronavirus outbreakOpioid overdoseFront lineSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Syringe driverDrug overdoseOpioidPandemicHuman immunodeficiency virus (HIV)Medical emergencyVirologyPsychiatryInternal medicinePoison control(+)-NaloxoneHistoryOutbreakNeoclassical economicsDiseaseArchaeologyInfectious disease (medical specialty)EconomicsReceptorHIV, Drug Use, Sexual RiskOpioid Use Disorder TreatmentCannabis and Cannabinoid Research